Post by Galderma

We are presenting new data from the longest extension study in prurigo nodularis at 2026 Winter Clinical™ Miami. The interim analysis explores the efficacy and safety of our treatment for prurigo nodularis up to three years.     This is part of our ongoing efforts to generate robust, long-term evidence in the treatment of chronic and debilitating skin conditions.     Learn more: https://lnkd.in/eYBGWNXv   #AdvancingDermatology #SkinSciencebyGalderma #ForInvestors